2017-03-07 21:31:38 UTC

AGA Institute GastroSlides Unit on Viral Hepatitis

About

Overview

“Hepatitis” is separated into the following sections: Part I: Virology and Immunology; Part II: Hepatitis A; Part III: Hepatitis B; Part IV: Hepatitis D; Part V: Hepatitis C Epidemiology; Part VI: Hepatitis C Diagnosis; Part VII: Hepatitis C Treatment; Part VIII: Hepatitis C Extrahepatic Disorders; Part IX: Hepatitis E; Part X: Beyond A to E; Part XI: Illustrative Cases; Part XII: Hepatitis C Liver Biopsy Staging.

Description:

This unit on viral hepatitis is an updated, high-quality, robust teaching module on the major causes of hepatitis caused by hepatotropic viruses. Topics include the epidemiology, virology, risk factors for acquisition of the disease, diagnosis, natural history, indications for vaccination and treatment modalities. The interplay between viral factors and the host response is explained elegantly in the immunology section. A substantial number of images are devoted to extrahepatic disorders associated with chronic hepatitis C virus infection.

The teaching is embellished by the incorporation of case studies and a wide-ranging spectrum of histological features. Radiological images and the use of data expressed in the form of bar graphs and pie charts complement the text slides. The legends provide important factual information that assist the speaker in making key teaching points. Updated references are incorporated in the legends.

The development of this unit is a tribute to the truly collaborative and collegial effort among the contributors. We have all learned much from each other and trust you will find this teaching unit to be highly informative and useful.

About the Instructors

Authors:

Sanjiv Chopra, MD, Senior Author
Faculty Dean for Continuing Education
Professor of Medicine
Harvard Medical School
Boston, MA

Nezam H. Afdhal, MD
Associate Professor of Medicine
Harvard Medical School
Chief of Hepatology
Director, Liver Center
Beth Israel Deaconess Medical Center
Boston, MA

Robert L. Carithers Jr., MD
Professor of Medicine
University of Washington
Director, Section of Hepatology
Division of Gastroenterology
Medical Director, Liver Transplantation Program
Seattle, WA

John B. Gross, MD
Associate Professor of Medicine
Head, Hepatobiliary Clinic
Mayo Clinic and Medical School
Rochester, MN

T. Jake Liang, MD
Chief, Liver Disease Branch
NIDDK, National Institutes of Health
Bethesda, MD

Anna S.F. Lok, MD
Professor of Internal Medicine
University of Michigan
Director of Clinical Hepatology
Ann Arbor, MI

Slide Production:

Jerry Schoendorf, MAMS
Duke University Medical Center

Acknowledgments

The authors gratefully acknowledge the following for their contributions to this teaching unit:

Andres Cardenas, MD
Hepatology Fellow
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

Imad Nasser, MD
Assistant Professor of Pathology
Hepatopathologist, Liver Center
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

Jean-Pierre Raufman, MD
Professor of Medicine
Head, Division of Gastroenterology and Hepatology
University of Maryland School of Medicine
Baltimore, MD

Helen M. Shields, MD
Associate Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, MA

Chun T. Yai, MD
Hepatology Fellow
University of Michigan
Ann Arbor, MI

Funded in part by an educational grant from Roche Laboratories, which had no involvement in the development of the images or content.

Published Date and Terms of Use

The content included in this GastroSlide set, Viral Hepatitis, was published on May 15, 2003. This slide set has not been updated since the date of publication and is provided “as is.” It is the learner's responsibility to evaluate the accuracy of any information found within these educational materials.

The intent of this series is to provide individual clinicians and educators with materials to use in their educational activities, such as lecturing at continuing medical education meetings and for self-education. AGA encourages all uses of GastroSlide materials consistent with this objective.

Materials are to be displayed in the same content and form as the original with no alterations unless approved by AGA. No materials may be reproduced for any purpose without written permission of AGA. Materials may only be used for educational purposes and may not be used to promote or advertise any pharmaceutical, medical device or organization.

This is only a preview. Full access is reserved for AGA members. Login or learn more about becoming a member.

Login

More on Hepatitis (other)

Building Foundations Among Payers & Providers for Collaborative Care in HCV & HIV

Dec. 7, 2017

In this video, leading experts in HCV, HIV, and managed care engage in a crossfire panel discussion on key challenges, considerations and solutions for improving patient management, and appropriate access to HCV and HIV therapies.

Risk Factors of Prednisolone May Outweigh Benefit in Treatment of Severe Alcoholic Hepatitis (SAH)

Aug. 17, 2017

Gastroenterology researchers discuss their findings in video abstract.

Previously Cured HCV Patients Can Be Reinfected

Aug. 3, 2017

Prevention will require attention to high-risk behaviors.